Cargando…
Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
BACKGROUND: Neuropathological, animal, and cell culture studies point to a role for the body's own endogenous cannabinoids (eCBs) system in Alzheimer's disease (AD) pathology and treatment. To date, no published studies have investigated the potential utility of circulating eCBs as diagnos...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631501/ https://www.ncbi.nlm.nih.gov/pubmed/19144193 http://dx.doi.org/10.1186/1476-511X-8-2 |